Home Blog Page 217

MALAYSIA’S GLOBAL UNIVERSITY ACHIEVEMENT SHOULD NOT BE MISREPRESENTED

By
Advertorial Desk
-

KUALA LUMPUR, Malaysia, July 5, 2026 /PRNewswire/ — Education Malaysia Global Services (EMGS) wishes to address recent public commentary which appears to question the validity of Malaysian universities’ global recognition in sustainability and impact-based rankings.

While public discourse on higher education is welcomed, it must be based on accurate context. The recent achievement of Universiti Sains Malaysia (USM) and Universiti Kebangsaan Malaysia (UKM) among the world’s top 10 universities refers specifically to the Times Higher Education (THE) Sustainability Impact Ratings 2026, not the QS World University Rankings.

In this ranking, USM was placed 5th globally, while UKM was ranked joint 7th globally, placing Malaysia among countries with two universities in the world’s top 10. THE Sustainability Impact Ratings assess universities’ contributions to the United Nations Sustainable Development Goals (SDGs), including sustainability, research, teaching, institutional responsibility and community impact.

Commenting on the matter, EMGS Chief Executive Officer, Novie Tajuddin, said:

“Malaysia’s achievement in the THE Sustainability Impact Ratings should not be dismissed or misrepresented simply because it is different from other global rankings. Each ranking has its own methodology and purpose. This recognition reflects how our universities are contributing to society, sustainability and global development, which are central to the true role of higher education.”

He added that Malaysia’s placement among the global top 10 is a national achievement that deserves fair recognition.

“To be listed alongside leading universities from Australia, Canada, the United Kingdom and other advanced higher education systems is not a small achievement. It reflects years of work by our universities in research, community engagement, sustainability and institutional responsibility. Questioning this recognition without proper context does a disservice to the efforts of our academic institutions,” he said.

EMGS also wishes to emphasise that international students, academic partners, governments and scholarship bodies refer to various credible global rankings, including THE, when evaluating universities. These rankings serve different purposes and collectively provide a broader view of institutional quality, reputation, impact and relevance.

Malaysia’s strong performance in THE Sustainability Impact Ratings reinforces the country’s position as a trusted and progressive international education destination. EMGS remains committed to promoting the Study in Malaysia brand globally and to presenting Malaysia’s higher education achievements accurately, confidently and responsibly.

EDUCATION MALAYSIA GLOBAL SERVICES (EMGS)

4 JULY 2026

About Education Malaysia Global Services (EMGS)

Education Malaysia Global Services (EMGS) is a Company Limited by Guarantee (“CLBG”) under the purview of the Ministry of Higher Education Malaysia. EMGS is the wing responsible for promoting Malaysia as the talent and knowledge hub and the preferred education destination among international students around the world. It is also the principal body that manages the movement of international students in Malaysia, including facilitating visa processing.


SCAN THE QR CODE TO FOLLOW EMGS

Prepared by: EDUCATION MALAYSIA GLOBAL SERVICES (EMGS)

Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics

By
Advertorial Desk
-

SHANGHAI and GUANGZHOU, China, July 4, 2026 /PRNewswire/ — Sanyou Biopharmaceutical Co., Ltd. (“Sanyou Bio”) and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. (“Baiyunshan Xihe”) jointly announced the official signing of a strategic cooperation agreement. This partnership will focus on the co-development of novel radiopharmaceuticals and radiodiagnostic products, aiming to integrate their respective core strengths in AI-driven innovative drug molecule discovery and the full industrial value chain of nuclear medicine. Together, the two parties seek to build an end-to-end innovation chain spanning from target molecule discovery to clinical translation of radiopharmaceuticals, delivering more transformative solutions for precision oncology diagnosis and therapy.

The development of radiopharmaceuticals and radiodiagnostic products places extremely high demands on the precision, stability, and druggability of targeting molecules. This strategic collaboration is based on both parties’ deep insight into the nuclear medicine industry trends and strong mutual recognition of each other’s technological capabilities.

Sanyou Bio will leverage its globally leading AI-Super trillion antibody/molecule libraries (AI-STAL) and its Sanyou AI-Drug Accelerator (SAI-DA) to provide source innovation power for the discovery and optimization of high-performance antibodies and targeting molecules against specific targets. Baiyunshan Xihe will rely on its end-to-end capabilities in novel medical radionuclide production, GMP manufacturing, and clinical translation to advance partnered molecules into radiolabeling, in vitro and in vivo evaluation, and preclinical studies, thereby accelerating the industrialization of innovative radiopharmaceuticals and radiodiagnostic products.

This strategic partnership aims to generate core value through deep integration across multiple dimensions:

1. Building an End-to-End Innovation Closed Loop:

Establish an integrated collaborative R&D model of “AI-driven molecular discovery – radionuclide labeling – clinical translation,” seamlessly connecting upstream molecular discovery capabilities with the radiopharmaceutical industrialization platform, significantly shortening the development timeline from target concept to radiopharmaceutical candidate compounds.

2. Developing a Differentiated Product Portfolio:

By combining Sanyou Bio’s extensive experience in innovative drug development and its strengths in AI-driven molecular discovery with Baiyunshan Xihe’s standardized production technologies for key medical radionuclides such as Gallium-68, Zirconium-89, Copper-64, and Rhenium-186, the two parties will jointly develop internationally competitive theranostic radiopharmaceuticals and novel radiodiagnostic products.

3. Building a New Industrial Ecosystem for Collaboration:

Both parties will integrate their deep resources in innovative drug R&D services and the nuclear medicine industry chain, jointly explore open and mutually beneficial collaboration models, enhance China’s upstream innovation capabilities in radiopharmaceuticals, and promote high-quality industry development.

Liu Hong, Chairman and General Manager of Baiyunshan Xihe, stated:

“We are very pleased to enter into this strategic collaboration with Sanyou Bio. As a leading enterprise in Guangzhou’s nuclear medicine industry chain, Baiyunshan Xihe has established a fully integrated value chain from radionuclide production to clinical services, and has developed a dual-track product portfolio featuring both self-developed nanobody-based RDCs and mature microsphere products. Sanyou Bio’s AI-STAL platform for upstream drug discovery is globally leading, with a library capacity exceeding 11 trillion and outstanding screening capabilities. This collaboration will strongly complement our capabilities in targeting molecule discovery and accelerate the layout and advancement of our theranostic radiopharmaceutical pipeline. We look forward to this deep integration of ‘discovery + translation’ to jointly develop truly clinically valuable innovative radiopharmaceutical products.”

Dr. Lang Guojun, Founder and CEO of Sanyou Bio, stated:

“This collaboration with Baiyunshan Xihe represents an important extension of Sanyou Bio’s mission—’To make it easy to develop new drugs worldwide’—into the cutting-edge field of nuclear medicine. Backed by the strong industrial resources of Guangzhou Pharmaceutical Holdings, Baiyunshan Xihe has built solid capabilities in radionuclide production and full value-chain integration. This strategic synergy is a key step in deeply connecting our AI-driven molecular discovery capabilities with a leading radiopharmaceutical industrialization platform. We believe that, through the dual engines of ‘intelligent molecular design’ and ‘precise radionuclide labeling,’ we can provide truly fundamental solutions to upstream innovation challenges in nuclear medicine, jointly empowering the technological upgrade of the global nuclear medicine industry.”

This strategic collaboration marks a solid step forward for Sanyou Bio in deepening industrial synergy and expanding into cutting-edge application areas. Starting from this partnership, both parties will continue to explore broader collaboration opportunities and strive to become a benchmark force driving upstream innovation in radiopharmaceutical development in China.

About Sanyou

Sanyou Biopharmaceuticals is a high-tech biopharmaceutical company driven by the mission of “To make it easy to develop new drugs worldwide”. The company is committed to fundamentally addressing the key challenges at the source of innovative drug development.

Powered by its AI-STAL and supported by Sanyou AI-Drug Accelerator (SAI-DA), Sanyou provides one-stop comprehensive solutions to tackle all challenges in molecular generation and innovative drug R&D.

Sanyou Bio has been dedicated to developing a world-class innovative biological drug R&D hub and to working collaboratively with partners worldwide to accelerate the development of innovative therapeutics.

Headquartered in Shanghai, China, Sanyou has established global business centers across Asia, North America, and Europe, forming an international business network. The company currently operates and has planned over 20,000 square meters of R&D and GMP facilities.

Sanyou has established strong collaborations with more than 2,000 pharmaceutical and biotech companies worldwide, empowering over 1,200 new drug discovery and development projects. It has completed more than 50 collaboration projects, over 10 of which have advanced to IND approval and clinical development stages.

The company has filed over 170 invention patents, with more than 30 granted. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai “Specialized and Innovative” Enterprise, ISO9001, and ISO27001.

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247

By
Advertorial Desk
-

Eligible clients can now trade Gold CFDs beyond the traditional trading week, including weekends, through MT5, TradingView and the Vantage App.

PORT VILA, Vanuatu, July 4, 2026 /PRNewswire/ — Vantage Markets (“Vantage”), a multi-asset CFD broker, today announced the launch of XAUUSD247. CME Group recently announced plans to expand trading of certain gold futures products to 24/7, subject to regulatory review. XAUUSD247 is a separate OTC CFD product offered by Vantage.


“XAUUSD247 provides eligible clients with access to gold CFDs beyond standard market hours, supported by transparent product mechanics and clearly defined trading controls,” said Marc Despallieres, Chief Executive Officer at Vantage.

XAUUSD247 is available 24 hours a day, seven days a week, including Saturdays and Sundays, subject to scheduled platform maintenance and regional availability. The product uses a one-ounce contract size, compared with the 100-ounce contract size of Vantage’s traditional XAUUSD product. No separate trading commission applies, although spreads, financing charges and other applicable costs may apply. Tiered leverage of up to 100x may be available, subject to position size, account type and applicable trading conditions. One-sided margin calculation for eligible accounts holding both long and short positions.

XAUUSD247 also incorporates net and gross exposure limits at account level as part of its risk-management framework. When the applicable exposure threshold is reached, accounts enter close-only mode until exposure returns below the relevant limit. Applicable spreads, financing charges, leverage, exposure limits and other trading conditions may vary depending on the client’s account type, region and applicable Vantage entity.

The page will be officially launched on 6 July.

About Vantage

Vantage Markets is a multi-asset CFD broker offering access to Gold, Forex, Commodities, Indices, Shares, ETFs, and Bonds.

With over 17 years of experience, Vantage provides a reliable trading platform, an award-winning mobile app, and a user-friendly trading experience.

Risk Warning: CFDs are complex leveraged products and carry a high risk of losing money rapidly due to leverage. Trading CFDs may not be suitable for all investors. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Disclaimer: This content is for informational purposes only and does not constitute financial or investment advice. Availability of products and services described in this release is subject to jurisdictional restrictions and may not be available to residents of certain countries or regions.

 

VinFast honored for investor relations excellence at the Asian Excellence Awards 2026

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 4 July 2026 – At the Asian Excellence Awards 2026 ceremony held in Hong Kong, VinFast was recognized with three prestigious awards, including Best Investor Relations Company and two individual honors. The achievement underscores VinFast’s growing stature and capabilities as a global electric vehicle company listed on Nasdaq.

VinFast honored for investor relations excellence at the Asian Excellence Awards 2026

The Asian Excellence Awards is one of Asia’s most prestigious accolades in the fields of corporate governance, ESG, and investor relations. Organized annually by Corporate Governance Asia since 2011, the awards are recognized for their rigorous evaluation standards and stringent selection criteria.

This year, VinFast received recognition in three major categories: Best Investor Relations Company, Asia’s Best CFO awarded to Ms. Nguyen Thi Lan Anh, and Best Investor Relations Professional awarded to Ms. Amandae Baey.

VinFast was the only Vietnamese company recognized at the 2026 awards. Other recipients this year were leading corporations from several key Asian markets, including Hong Kong, Mainland China, Taiwan, Thailand, Malaysia, Indonesia, and the Philippines.

In the Best Investor Relations Company category, VinFast was highly regarded for its transparency in information disclosure, its ability to maintain regular engagement with investors and analysts, and the effectiveness of its communication and outreach initiatives with financial communities.

For the Asia’s Best CFO award, the organizers recognized the critical role of corporate finance leaders in maintaining strong financial foundations, developing effective capital-raising strategies, and navigating market volatility. The award honors CFOs who demonstrate exceptional leadership in guiding their companies toward stable and sustainable growth across varying economic conditions.

Ms. Nguyen Thi Lan Anh, Chief Financial Officer of VinFast, said: “This series of recognitions at the Asian Excellence Awards 2026 is a meaningful acknowledgment of VinFast’s journey in building a global enterprise founded on advanced and sustainable governance standards. VinFast will continue to strengthen governance capabilities, enhance transparency, and foster open dialogue with stakeholders to build long-term trust in international markets.”

Ms. Nguyen Thi Lan Anh has served as Chief Financial Officer (CFO) of VinFast Auto Ltd since 2024. Having joined Vingroup in 2020, she brings extensive knowledge of the Company’s operations through her leadership experience across multiple functions, including finance, manufacturing, and supply chain management. She is a Fellow Chartered Certified Accountant (FCCA) and a Certified Practising Accountant of CPA Australia.

Ms. Amandae Baey has served as Vice President of Investor Relations at VinFast since 2024, where she leads the Company’s global investor engagement, analyst relations, and capital markets positioning. She is a CFA charterholder.

The awards highlight VinFast’s increasing integration into global capital markets and reaffirm its commitment to adopting international governance standards, enhancing disclosure quality, and strengthening engagement with shareholders and investors through a professional, proactive, and sustainable approach.

Over the past year alone, VinFast has received dozens of prestigious international awards spanning investment and finance, corporate communications, electric mobility, technology, design, and sustainability. Notable recognitions include the “Outstanding Innovation in Sustainable Electric Mobility” and “Remarkable Contribution to Energy Independence” awards at the CNN Indonesia Awards; the “Best Value Car of the Year” award at the Autocar India Awards 2026; ranking 101st in TIME magazine’s “Asia-Pacific’s Best Companies of 2025” list; and six awards at the APAC Effie Awards.

Hashtag: #VinFast #AsianExcellenceAwards #InvestorRelations

The issuer is solely responsible for the content of this announcement.

About Corporate Governance Asia

Corporate Governance Asia is Asia’s leading publication covering corporate governance, ESG (Environmental, Social and Governance), investor relations, and sustainability. Since its launch in 2002, it has become a trusted source of insights and analysis for corporate leaders, investors, regulators, and financial professionals across the region.

The Asian Excellence Awards, organized annually by Corporate Governance Asia since 2011, recognize outstanding companies and business leaders across Asia for excellence in corporate governance, ESG practices, and investor relations.

JACK’S PLACE CELEBRATES 60 YEARS OF CULINARY HERITAGE WITH A SPECIAL “TASTE OF SINGAPORE” SELECTION

By
Advertorial Desk
-

SINGAPORE, July 4, 2026 /PRNewswire/ — Jack’s Place, the pioneer homegrown Western steakhouse chain with roots dating back to 1966, proudly announces its third seasonal menu launch for July and August 2026, marking a special highlight of its landmark 60th Anniversary celebration.

To commemorate six decades of service to the local community, Jack’s Place is rolling out a limited-time seasonal menu for July and August titled “A Taste of Singapore”. This special culinary rollout is launched in alignment with Singapore’s upcoming National Day celebrations on 9th August.

This anniversary celebration serves as a grand tribute to a heritage of flavours crafted specifically for Singapore. The curated menu brings together familiar, deeply loved local dishes that highlight the nation’s vibrant culinary traditions, seamlessly integrated with the classic steakhouse comfort that has defined the brand for generations.

Six Decades of Steakhouse Excellence

Founded in 1966, Jack’s Place began as a modest eatery serving quality sizzling steaks and hearty Western meals. Over the past sixty years, the brand has grown into a trusted household name across Singapore, woven into the fabric of family milestones, celebrations, and everyday gatherings. The 60th Anniversary marks a significant milestone in the brand’s history, celebrating both its classic heritage and its ongoing evolution within Singapore’s dynamic food and beverage landscape.

The upcoming “A Taste of Singapore” menu for July and August represents a purposeful fusion of Western culinary techniques with iconic local flavours. By reimagining traditional Singaporean staples through the lens of a classic steakhouse, Jack’s Place aims to offer a nostalgic yet distinct dining experience that honors its sixty-year history of serving local palates.

An Anniversary Selection Recommended By Celebrity Chef Eric Teo

To elevate this milestone celebration, Jack’s Place welcomes Celebrity Chef & Culinary Mentor Eric Teo as a featured guest for the anniversary celebration. Having closely witnessed the growth and presence of Jack’s Place in the local dining scene over the decades, Chef Eric Teo serves as the guest recommender for this seasonal menu showcase.

The “Taste of Singapore” July-August seasonal menu highlights comfort-focused creations that celebrate local food heritage while maintaining the core flavours that diners have enjoyed for generations. Chef Eric Teo lends his extensive culinary expertise to endorse and recommend this specific anniversary selection, noting that these familiar flavours hold a special, enduring place in the hearts of many local diners.

The “Taste Of Singapore” Cuisine Line-Up

The “A Taste of Singapore” seasonal menu features an extensive array of individual main courses and premium sharing platters designed for group celebrations, the promotional offerings include:

1. Jack’s Place Sharing Platter Sets for 2 from $63.80++ (Ala Carte & Sets)

For patrons celebrating in groups, the menu features sharing platters available as a la carte dish or as a Set for 2:

Singapore Sharing Platter with Cereal Prawns ($40.80 Ala Carte / $63.80 Set for 2): A robust assortment featuring sambal grilled dory, chicken satay accompanied with a rich peanut gravy, traditional orh-luak (oyster omelette) served with chinchalok chilli, fragrant coconut rice, and a refreshing side of achar-mesclun salad.

Deluxe Sharing Platter – Whole Lobster Feast ($60.80 Ala Carte / $83.80 Set for 2): A premium rendition of the sharing concept, anchoring the platter with a generous garlic butter lobster (±500g). The feast is rounded out with sambal grilled dory, chicken satay with peanut gravy, orh-luak with chinchalok chilli, fragrant coconut rice, and achar-mesclun salad.

When ordered as a Sharing Platter set for 2, both the Singapore Sharing Platter (with Cereal Prawns) and the Deluxe Sharing Platter (featuring the Whole Lobster Feast) come with a curated selection of appetizers, soups, drinks, and desserts.

  • Signature Soups: A choice of two bowls, with options including the classic Lobster Bisque or Cream of Shiitake Mushroom.
  • Cheesy Otah Stuffed Mushrooms: A savoury starter featuring tender mushrooms stuffed with mildly spicy local otah and baked with melted mozzarella cheese.
  • Mao Shan Wang Durian Choux Puffs: A decadent dessert filled with rich, creamy MSW durian pulp.
  • Green Apple Lime Fizz: Two glasses of a refreshing seasonal beverage enhanced with  Osmanthus Popping Jelly.

2. Jack’s Place “Taste of Singapore” Seasonal Menu Main Courses

In addition to the Sharing platters, the July and August menu introduces individual main courses that highlight local-Western fusion elements:

N.Z. Tenderloin Steak with Chicken Satay ($33.80): A premium New Zealand tenderloin steak paired with tender chicken satay, served with a signature Hainanese pineapple satay sauce and a choice of two customizable side dishes.

Grandma’s Beef Ragoût Spaghetti ($18.80): Comfort food featuring spaghetti sautéed with tender braised beef in a rich, slow-simmered ragoût sauce, elevated with a silky onsen egg and finished with shaved Parmesan cheese.

Hainanese Chicken Cutlet ($16.80): A golden, crunchy chicken cutlet prepared in the traditional Hainanese style, served alongside a choice of two sides.

3. Customizable Dining Sides

To complement the individual main courses, diners can select two sides for the N.Z Tenderloin Steak with Chicken Satay and Hainanese Chicken Cutlet, including:
French Fries, Mashed Potato, Signature Baked Potato, Seasonal Vegetables, Achar-Mesclun Salad.

4. Anniversary Promotions And Interactive Engagement

To enhance the dining experience throughout the July and August celebration period, there is the exclusive Add-On Special. Diners who order any promotional main course or sharing platter from the “A Taste of Singapore” menu are eligible to enjoy a 20% discount on the Cheesy Otah Stuffed Mushrooms appetiser.

Furthermore, the brand is launching an interactive Social Media Contest to engage the community. To participate, diners are invited to share their dining experiences by posting photos of their meals or celebrations at Jack’s Place outlets on Facebook or Instagram. Posts must include the official tags (@jacks.place.restaurant or @eatzigourmet.bistro on Facebook; @jacksplacesg or @eatzigourmetsteakhouse on Instagram) and the hashtags #SG61, #jacksplacesg, #GoBeyond, and #eatzigourmetsteakhouse.

Three winners will be selected to receive a complimentary Singapore Sharing Platter Set for two, valued at $63.80 each. The contest closes on August 10, 2026, and winners will be announced by August 14, 2026.

Jack’s Place marks its 60-year milestone, extending heartfelt gratitude to its diners and customers who have been an integral part of its journey. For latest information, please visit www.jacksplace.com.sg

Join the Celebration.
#JP60 #JacksPlaceSG #JPPepperdine

Also available for diners at Eatzi Gourmet Steakhouse & Bistro, the Halal-certified sibling restaurant of Jack’s Place – located at SAFRA Yishun.

Prices stated are subject to GST taxes and services charge.

For more information, visit www.jacksplace.com.sg

Website: www.jacksplace.com.sg
Facebook: www.facebook.com/jacks.place.restaurant
Instagram: www.instagram.com/jacksplacesg
Official hashtag: #jacksplacesg

About Jack’s Place

Established in 1966, Jack’s Place is the trusted favourite known for its Western food. It all started when Mr. Say Lip Hai arrived in Singapore from Hainan Island and started as a cook boy with the British troops in Sembawang. There he learned how to prepare the perfect roast beef and Yorkshire pudding.

Having tasted one of Mr Say’s now famous meals, a British housewife suggested he start a catering business with her husband, Jack Hunt, in his pub at Killiney Road, Jack’s Place, which he started in 1966. Mr Say agreed and commenced that partnership in 1968. Shortly afterwards, Jack Hunt sold his share of the business, but his namesake ‘Jack the Chef’ still runs the kitchen today!

Today, Jack’s Place is the trusted favourite for family and friends to enjoy great value sizzling steaks, speciality meals, and sumptuous cakes. Jack’s Place is committed to serving quality food and creating memorable dining experiences in a cheerful and cosy environment for our guests.

For more information, visit www.jacksplace.com.sg.

About JP Pepperdine

JP Pepperdine is a group of restaurants that started with the popular Jack’s Place Steakhouse in 1966, followed by Eatzi Gourmet divisions (Steakhouse, bakery, and catering).

What inspires JP Pepperdine is to create a unique experience for their guests. Interestingly, it is a lesson that they take from the kitchen itself. Drawing on the admirable qualities of pepper, JP Pepperdine aspires to spice up the dining experience in all ways, big and small. In big ways, JP Pepperdine will be adventurous, sizzling up the F&B scene with fresh concepts and food creations. In small ways, JP Pepperdine dedicates itself to delighting its patrons through its food, service, and ambience, so they are now the JP Pepperdine Group, named after that extraordinary spice itself.

In all that JP Pepperdine does, quality and value will always be their benchmarks. They hope that the guests take home with them a lingering fondness and the knowledge that for the price they pay, they have much more in return.

For more information, visit www.jppepperdine.com.

Issued for and on behalf of Jack’s Place by Olive & Latte-ABS.

For media enquiries, please contact:
Sharon Vu 
Olive & Latte-Abs
https://oliveandlatte.com , https://engagevu.com
https://engagevu.biz
Mobile: (65) 8138 6913
Whatsapp: (65) 9832 8129
Email: sharonvu@oliveandlatte.com

JMGO Offers Special Savings on 4K Projectors Ahead of the Tournament Final

By
Advertorial Desk
-

SHENZHEN, China, July 4, 2026 /PRNewswire/ — As the tournament reaches its final stage, JMGO is offering limited-time savings on its award-winning 4K projector lineup through July 19. Featuring the N3 Ultimate, N1S 4K and N1S Ultimate, the promotion gives sports fans an easy way to enjoy every goal, replay and celebration on an immersive big screen with vibrant triple-laser visuals and effortless setup. The offers are available through the JMGO Webstore and on Amazon.

JMGO N3 Ultimate
JMGO N3 Ultimate

JMGO N3 Ultimate: Premium Home Theater, Ready in Seconds

From kickoff to the final whistle, the N3 Ultimate delivers premium home theater with effortless setup, so you never miss a moment of the tournament final. Featuring the world’s first 3-in-1 optical system, which integrates optical zoom, lens shift and an AI-powered gimbal, the N3 Ultimate automatically delivers an optimized image in seconds. Powered by the latest MALC™ 5.0 triple-laser engine and delivering up to 5,800 ISO lumens, it produces exceptional brightness and cinematic detail for every scene.

The N3 Ultimate is now available at 20% off through July 19. Customers can enjoy an additional 10% off with code JMGOBESTN3U on the JMGO Webstore and Amazon, bringing the final price to $2,159. Every purchase also includes complimentary viewing accessories.

JMGO N1S 4K: A Portable 4K Projector for Match Day

Whether you’re hosting friends in the backyard, relaxing on the patio or taking the projector on a summer getaway, the N1S 4K brings premium big-screen entertainment almost anywhere. Weighing just 2.2 kg (4.9 lbs), it combines 4K resolution, JMGO’s triple-color laser technology, Google TV with licensed Netflix and a built-in 127° gimbal, making premium projection simple wherever the match takes you.

The N1S 4K is now available at 46% off for $699 (MSRP $1,299) through July 19 on the JMGO Webstore and Amazon.

JMGO N1S Ultimate: A Step Up for Home Theater Enthusiasts

For viewers ready to upgrade their home entertainment experience, the N1S Ultimate combines premium 4K projection with JMGO’s triple-laser technology for rich colors, lifelike detail and effortless everyday viewing. Powered by JMGO’s MALC™ triple-laser optical engine, it features 3,300 ISO lumens, 4K resolution and Google TV, delivering immersive visuals across live sports, movies and streaming content. An integrated smart gimbal makes setup quick and easy in virtually any room.

The N1S Ultimate is now available at 46% off for $1,499 (MSRP $2,799) through July 19 on the JMGO Webstore and Amazon, including complimentary viewing accessories.

About JMGO

Founded in 2011, JMGO is a leader in intelligent projection technology, combining innovative design and advanced imaging solutions to create immersive entertainment experiences for consumers worldwide. To learn more, visit JMGO.com

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247

By
Advertorial Desk
-

Eligible clients can now trade Gold CFDs beyond the traditional trading week, including weekends, through MT5, TradingView and the Vantage App.

PORT VILA, Vanuatu, July 4, 2026 /PRNewswire/ — Vantage Markets (“Vantage”), a multi-asset CFD broker, today announced the launch of XAUUSD247. CME Group recently announced plans to expand trading of certain gold futures products to 24/7, subject to regulatory review. XAUUSD247 is a separate OTC CFD product offered by Vantage.

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247

“XAUUSD247 provides eligible clients with access to gold CFDs beyond standard market hours, supported by transparent product mechanics and clearly defined trading controls,” said Marc Despallieres, Chief Executive Officer at Vantage.

XAUUSD247 is available 24 hours a day, seven days a week, including Saturdays and Sundays, subject to scheduled platform maintenance and regional availability. The product uses a one-ounce contract size, compared with the 100-ounce contract size of Vantage’s traditional XAUUSD product. No separate trading commission applies, although spreads, financing charges and other applicable costs may apply. Tiered leverage of up to 100x may be available, subject to position size, account type and applicable trading conditions. One-sided margin calculation for eligible accounts holding both long and short positions.

XAUUSD247 also incorporates net and gross exposure limits at account level as part of its risk-management framework. When the applicable exposure threshold is reached, accounts enter close-only mode until exposure returns below the relevant limit. Applicable spreads, financing charges, leverage, exposure limits and other trading conditions may vary depending on the client’s account type, region and applicable Vantage entity.

The page will be officially launched on 6 July.

About Vantage

Vantage Markets is a multi-asset CFD broker offering access to Gold, Forex, Commodities, Indices, Shares, ETFs, and Bonds.

With over 17 years of experience, Vantage provides a reliable trading platform, an award-winning mobile app, and a user-friendly trading experience.

Risk Warning: CFDs are complex leveraged products and carry a high risk of losing money rapidly due to leverage. Trading CFDs may not be suitable for all investors. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Disclaimer: This content is for informational purposes only and does not constitute financial or investment advice. Availability of products and services described in this release is subject to jurisdictional restrictions and may not be available to residents of certain countries or regions.

Straits Forum | Taiwanese Youth Tells: Six Years Rooted in the Mainland – From Starting a Business to Ringing the Bell at HKEX

By
Advertorial Desk
-

XIAMEN, China, July 3, 2026 /PRNewswire/ — This is a news report by Hong Kong Ta Kung Wen Wei Media Group Limited:


The 18th Straits Forum was held on June 13 in Xiamen, Fujian, China. At the forum, three Taiwanese youths from different fields shared their wonderful stories of working and living in the mainland. “Our success benefits from the mainland’s very complete innovation system, abundant data resources, high-quality talent pool, active capital market, and comprehensive policy support.” Chris Lai, co-founder, chairman and CEO of Metis TechBio Co., Ltd., shared how, after graduating with a PhD from MIT, he returned to the mainland and received full support from the governments of Hangzhou and Beijing in terms of funding, talent, and industrial chains. By integrating artificial intelligence with biomedicine, after six years of hard work, Metis TechBio Co., Ltd. successfully rang the bell at the Hong Kong Stock Exchange in May this year, becoming the world’s first AI-driven drug delivery listed company.

The germ of scientific research aspiration gives rise to entrepreneurial ideas

Chris Lai’s connection with gene editing and biomedicine began in high school. After graduating from university, he went abroad to pursue a doctoral degree. Upon graduation in 2017, at a café in Massachusetts, he discussed the development prospects of AI in manufacturing with his now-partner, Professor Hongmin Chen, a member of the U.S. National Academy of Engineering. At that time, the new nano-drug developed by the other team had just been successfully launched. Right there, they sketched out their entrepreneurial blueprint on a napkin: to build a professional laboratory in the pharmaceutical field, relying on AI technology to achieve precise nano-delivery of drugs, repair diseased cells, and explore anti-aging directions for cells.

Rooting in the mainland for entrepreneurship, deepening technology to achieve breakthroughs

But limited by the technology level at the time, and with the industry generally taking a wait-and-see attitude, this plan did not officially materialize until 2019. “That year, our project won the second prize in the Hangzhou Maker Competition and received RMB 10 million in funding support.” In Hangzhou, the local government provided concierge-style services, assisting with company registration, site selection, providing talent apartments and various subsidies, and proactively connecting industry resources to fully support the technology team’s development. It took less than three months to complete the renovation of the experimental site, helping to quickly build an experimental platform. “These made us determined to root our entrepreneurship in the mainland.”

The entrepreneurial journey was full of challenges. In the early stages, various AI-developed drug carriers failed repeatedly in animal experiments, putting tremendous pressure on the team. Fortunately, Hangzhou continued to connect various R&D resources, supporting Chris Lai’s team to experiment repeatedly and iterate continuously. Over three years, Chris Lai’s team built a globally leading dry-wet experimental data platform and a tens-of-millions-level industry knowledge base.

“With AI technology, we dramatically reduced costs and improved efficiency, compressing the clinical R&D cycle for nano-materials from several years to several months, completely disrupting the traditional industry model.” With policy support and multiple rounds of financing, in just a few years, Chris Lai’s company grew into an industry unicorn. The nucleic acid drug design platform project led by Chris Lai was also selected as a national key biomedical technology breakthrough project.

Mainland’s AI leads globally, young people become the main force

Chris Lai remarked that starting a business in the mainland is vastly different from doing so overseas. “In the U.S. pharmaceutical industry, young scientists like me, though technology leaders, can usually only work at the technical level and are unlikely to be involved in company management; the industry ceiling is very low. But in China, it’s completely different. This is an era of young people. Entrepreneurs born after 1985, 1990, or even 2000 have become the main force, achieving various breakthroughs in deep AI application development, which deeply moves me.” Chris Lai said that China has already taken the lead globally in artificial intelligence, and AI is now transforming every industry and has become an innovation booster in biomedicine.

Chris Lai introduced that the team has set up a new R&D center in Beijing’s Zhongguancun, bringing together top talents from Peking University, Tsinghua University, the National Center for Nanoscience and Technology, and others, with a well-established medical investment system and industry guidance funds. “Within just a few months after settling in, the local authorities helped us connect with international pharmaceutical companies, vaccine enterprises, and clinical hospitals, empowering our hard-tech breakthroughs along the entire chain.” Today, Chris Lai’s AI nano-drug delivery platform can precisely deliver drugs to multiple organs such as the liver, lungs, heart, and gastrointestinal tract, like building a dedicated “drug rocket” inside the body, opening up a brand-new technological track.

The mainland has sincerity, policies, and warmth

On May 13 this year, Metis TechBio Co., Ltd. was listed on the Main Board of the Hong Kong Stock Exchange, becoming the world’s first AI drug delivery listed company. Chris Lai also became the first Taiwanese youth to take a hard-tech enterprise from zero to IPO in mainland China. Looking back, the partners who studied with Chris Lai at the time are now starting businesses in different cities. The small team of six people has now incubated four listed and pre-listed companies.

“As a beneficiary of cross-strait integrated development, I want to say to Taiwanese youth: the mainland has sincerity, policies, and warmth for Taiwanese youth. As long as you are willing to come, stay down-to-earth, and combine your expertise with the industrial advantages here, you will surely find your own stage.” Chris Lai encouraged Taiwanese youth, saying that artificial intelligence is a young cause and also a cause for young people. This is a critical stage for building a strong country and achieving national rejuvenation. He hopes that young people on both sides of the strait will join hands, transform technological creativity into tangible products, and realize personal value in the journey of national rejuvenation.

1...216217218...6,508Page 217 of 6,508